Updates in Management of SARS-CoV-2 Infection

• Eará dahkkit: Flisiak, Robert (Doaimmaheaddji)
• Materiálatiipa: Elektrovnnalaš Girjji oassi
• Giella: eaŋgalasgiella
• Almmustuhtton: MDPI - Multidisciplinary Digital Publishing Institute 2022
• Fáttát: Medicine; COVID-19; SARS-CoV-2; interleukin-6; tocilizumab; therapy; coronavirus disease 2019; cytokines; severity; prognosis; mortality; kidney failure; rapid diagnostic test; antigen detection; Cytomegalovirus; co-infections; critical care; liver markers; inflammation; morbidity; personalized medicine; liver functional tests; COVID-19 pneumonia; meta-analysis; trial sequential analysis; children; clinical presentation; coronavirus disease 2019 (COVID-19); epidemiology; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); clinical outcome; symptomatology; pandemic; angiotensin 1 receptor (AT1R); AT1R concentration; angiotensin II; symptoms' severity; diagnosis; artificial intelligence; medical imaging; systematic umbrella review; methodological credibility; PCR test; COVID-19 diagnosis; Charlson Comorbidities Index; cluster analysis; longitudinal cluster; individualized management; n/a
• Liŋkkat: DOAB: download the publication; DOAB: description of the publication

Severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) has spread worldwide from the beginning of 2020. The infection is mostly asymptomatic but some patients may develop COVID‑19 (coronavirus disease 2019) with a severe or critical course leading to pneumonia, acute respiratory distress syndr...